In patients taking placebo, four of six patients undergoing radiotherapy and two of seven patients treated with chemotherapy had an ejection fraction reduction of 10 percent or more
"The FDA submission of CagriSema marks an important milestone and signals a new era in weight management, reinforcing Novo Nordisk's long-standing commitment to serving people living with obesity through innovation and science," said Mike Doustdar, president and CEO of Novo Nordisk
Check it out today!
We also offer many other health services including Pharmacy First, Flu Vaccination, Blood Pressure Testing, and Weight Loss Injections (Mounjaro)
QC samples were included in the analysis sequence every ten samples and monitored for changes in peak area, width, and retention time to determine the performance of the LC-MS/MS analysis
This can be incredibly frustrating and concerning, especially for individuals who are not pregnant